Skip to main content
Clinical Trials/CTRI/2016/05/006957
CTRI/2016/05/006957
Active, not recruiting
Phase 4

The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS) - CoreValveTM India (PMS)

India Medtronic Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Symptomatic Aortic Stenosis
Sponsor
India Medtronic Pvt Ltd
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Pms

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with symptomatic heart disease due to severe native calcific aortic stenosis or a stenosed, insufficient, or combined surgical bioprosthetic valve failure and with anatomy appropriate for the 23, 26, 29 or 31 mm valve system who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy.
  • Indications and contraindications are provided in the product Instructions for Use.
  • Subject is scheduled to receive transcatheter aortic valve
  • Subject is 18 years of age or older
  • The patient or his/her Legally Authorized Representative (LAR) has been informed about the nature of the PMS and the Informed consent for both Audio Visual (AV) recording and for study participation has been obtained prior to performing any study\-related procedures from the subject or Legally Authorized Representative, as per applicable local requirements in India

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials